LB
ARKG icon

Leo Brokerage’s ARK Genomic Revolution ETF ARKG Stock Holding History

Leo Brokerage’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$277K Buy
3,701
+24
+0.7% +$2.01K 0.05% 152
2021
Q2 		$340K Hold
3,677
– – 0.07% 141
2021
Q1 		$326K Buy
+3,677
New +$365K 0.09% 140

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Leo Brokerage's ARKG Position: Q3 2021 in Review

Leo Brokerage increased its ARK Genomic Revolution ETF (ARKG) stake by 0.65% in Q3 2021, buying an estimated $2.01K and bringing the position to 3,701 shares worth $277K. The position accounts for 0.05% of the portfolio, ranked #152.

Leo Brokerage first reported a position in ARKG in Q1 2021 and has held it in 3 quarters since. The position peaked at $340K in Q2 2021. 468 funds tracked by Wall St. Rank hold ARKG as of Q3 2021.

  • Leo Brokerage held 3,701 shares of ARK Genomic Revolution ETF worth $277K as of Q3 2021.
  • Leo Brokerage bought 24 ARK Genomic Revolution ETF shares in Q3 2021, an estimated $2.01K.
  • ARK Genomic Revolution ETF made up 0.05% of Leo Brokerage's portfolio in Q3 2021, its #152 holding.
  • Leo Brokerage first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 3 quarters since.
  • Leo Brokerage's ARK Genomic Revolution ETF position peaked at $340K in Q2 2021.
  • 468 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2021.

Based on Leo Brokerage's 13F filing for Q3 2021, filed 13 Oct 2021.